Trials / Conditions / Indeterminate Lesions
Indeterminate Lesions
4 registered clinical trials studyying Indeterminate Lesions — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | A Long-Term Follow-Up Study of Subjects Completing the AU-011-301(CoMpass) for Early Choroidal Melanoma NCT07338968 | Aura Biosciences | — |
| Recruiting | Choroidal Melanoma Patient-Reported Outcome Study (CM-PRO) in a Subset of AU-011-301 (CoMpass) Subjects NCT07421739 | Aura Biosciences | — |
| Recruiting | A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-0 NCT06007690 | Aura Biosciences | Phase 3 |
| Terminated | Prospective Group-Matched Study With Belzupacap Sarotalocan (Bel-sar; AU-011) or Plaque Radiotherapy for Prima NCT05266430 | Aura Biosciences | — |